EPHB2 and major depressive disorder: EPHB2, which is involved in the regulation of synaptic enhancement, cation channel activity, neuron projection retraction, central nervous system neuron development and MAPKK activity, was downregulated in both the HIP (P = 0.0009) and PFC (P = 0.0048) of MDD patients (Figures 7C,D).